Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | ARG1 | P05089 | 5/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.39 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.39 |
| ▸ | ARG2 | P78540 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL351910 | 1.00 | MEN1 (0.63) | MEN1BLMKMT2AARG1SLC1A2 | |
| SCHEMBL2964302 | 1.00 | MEN1 (0.63) | MEN1BLMKMT2AARG1SLC1A2 | |
| SCHEMBL17943259 | 1.00 | MEN1 (0.63) | MEN1BLMKMT2AARG1SLC1A2 | |
| SCHEMBL3260294 | 1.00 | MEN1 (0.63) | MEN1BLMKMT2AARG1SLC1A2 | |
| SCHEMBL12909421 | 1.00 | MEN1 (0.63) | MEN1BLMKMT2AARG1SLC1A2 | |
| Hydrochloric Acid SCHEMBL28578650 | 0.98 | MEN1 (0.61) | MEN1BLMKMT2AARG1SLC1A2 | |
| SCHEMBL18561419 | 0.91 | MEN1 (0.53) | MEN1BLMKMT2AARG1SLC1A2 | |
| SCHEMBL1364961 | 0.86 | — | — | |
| SCHEMBL114870 | 0.86 | — | — | |
| SCHEMBL2025245 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12415992-B2 | Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid | JIANGNAN UNIVERSITY (CN) | 2025-09-16 | — | — | US | claimed |
| US-20250179542-A1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | CODEXIS INC (US) | 2025-06-05 | — | — | US | claimed |
| US-20250171748-A1 | DIOXYGENASE MUTANTS AND USE THEREOF IN SYNTHESIZING (2S,3R)-3-HYDROXYPIPECOLIC ACID | JIANGNAN UNIVERSITY (CN) | 2025-05-29 | — | — | US | claimed |
| US-12247234-B2 | Biocatalysts and methods for hydroxylation of chemical compounds | CODEXIS, INC. (US) | 2025-03-11 | — | — | US | claimed |
| US-20230227875-A1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2023-07-20 | — | — | US | claimed |
| US-11549132-B2 | Biocatalysts and methods for hydroxylation of chemical compounds | CODEXIS, INC. (US) | 2023-01-10 | — | — | US | claimed |
| CN-107699548-B | Biocatalysts and methods for hydroxylation of chemical compounds | 科德克希思公司 | 2021-10-22 | — | — | CN | claimed |
| US-20210230654-A1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2021-07-29 | — | — | US | claimed |
| US-10995349-B2 | Engineered proline hydroxylase polypeptides and methods | CODEXIS, INC. (US) | 2021-05-04 | — | — | US | claimed |
| US-20200325510-A1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2020-10-15 | — | — | US | claimed |
| US-10731189-B2 | Engineered proline hydroxylase polynucleotides and methods | CODEXIS, INC. (US) | 2020-08-04 | — | — | US | claimed |
| US-20190323046-A1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2019-10-24 | — | — | US | claimed |
| EP-2847327-B1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | CODEXIS INC (US) | 2018-12-26 | — | — | EP | claimed |
| US-9790527-B2 | Engineered proline hydroxylase polypeptides | CODEXIS, INC. (US) | 2017-10-17 | — | — | US | claimed |
| US-20150118719-A1 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2015-04-30 | — | — | US | claimed |
| EP-2847327-A2 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | Codexis, Inc. (US) | 2015-03-18 | — | — | EP | claimed |
| WO-2013169725-A2 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | CODEXIS, INC. (US) | 2013-11-14 | — | — | WO | claimed |
| US-12415992-B2 | Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid | JIANGNAN UNIVERSITY (CN) | 2025-09-16 | — | — | US | disclosed |
| US-6670386-B2 | For therapy of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia | BRISTOL-MYERS SQUIBB COMPANY | 2003-12-30 | — | — | US | disclosed |
| US-20030055094-A1 | Bicyclic modulators of androgen receptor function | BRISTOL-MYERS SQUIBB COMPANY | 2003-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055094-A1 | Bicyclic modulators of androgen receptor function | AR, NR5A1, ESRRA | MEN1 3920/4885BLM 3884/4885KMT2A 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.